Nrx Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 3.9
| NRXP Stock | USD 1.51 0.01 0.66% |
NRX |
NRX Pharmaceuticals Target Price Odds to finish below 3.9
The tendency of NRX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 3.90 after 90 days |
| 1.51 | 90 days | 3.90 | close to 99 |
Based on a normal probability distribution, the odds of NRX Pharmaceuticals to stay under $ 3.90 after 90 days from now is close to 99 (This NRX Pharmaceuticals probability density function shows the probability of NRX Stock to fall within a particular range of prices over 90 days) . Probability of NRX Pharmaceuticals price to stay between its current price of $ 1.51 and $ 3.90 at the end of the 90-day period is about 18.88 .
Given the investment horizon of 90 days NRX Pharmaceuticals has a beta of 0.7. This indicates as returns on the market go up, NRX Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NRX Pharmaceuticals will be expected to be much smaller as well. Additionally NRX Pharmaceuticals has an alpha of 0.0256, implying that it can generate a 0.0256 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). NRX Pharmaceuticals Price Density |
| Price |
Predictive Modules for NRX Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NRX Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NRX Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NRX Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NRX Pharmaceuticals is not an exception. The market had few large corrections towards the NRX Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NRX Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NRX Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | 0.70 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | 0 |
NRX Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NRX Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NRX Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NRX Pharmaceuticals had very high historical volatility over the last 90 days | |
| NRX Pharmaceuticals may become a speculative penny stock | |
| NRX Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRX Pharmaceuticals currently holds about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| NRX Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Javitt Jonathan C of 40000 shares of NRX Pharmaceuticals at 1.17 subject to Rule 16b-3 |
NRX Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NRX Stock often depends not only on the future outlook of the current and potential NRX Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NRX Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.6 M | |
| Cash And Short Term Investments | 4.6 M |
NRX Pharmaceuticals Technical Analysis
NRX Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. NRX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NRX Pharmaceuticals. In general, you should focus on analyzing NRX Stock price patterns and their correlations with different microeconomic environments and drivers.
NRX Pharmaceuticals Predictive Forecast Models
NRX Pharmaceuticals' time-series forecasting models is one of many NRX Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NRX Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NRX Pharmaceuticals
Checking the ongoing alerts about NRX Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NRX Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NRX Pharmaceuticals had very high historical volatility over the last 90 days | |
| NRX Pharmaceuticals may become a speculative penny stock | |
| NRX Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRX Pharmaceuticals currently holds about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| NRX Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Javitt Jonathan C of 40000 shares of NRX Pharmaceuticals at 1.17 subject to Rule 16b-3 |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.